A groundbreaking study has successfully translated high-field nuclear magnetic resonance (NMR) spectroscopy-based lipoprotein ...

Lipoprotein(a), or Lp(a), is a protein that transports cholesterol in the blood. High levels of Lp(a) in the blood can increase the likelihood of plaques or blood clots forming in the arteries.

NEW research employing Mendelian randomisation (MR) analysis has identified a potential causal relationship between lipid ...

For people who quit after drinking 1.5 drinks per day or less, their LDL rose 1.10 mg/dL, and their HDL fell by 1.25 mg/dL.

This new perspective creates opportunities to innovatively address lipoprotein alterations and associated risks. The study was conducted as an observational cohort study at Sant Pau Hospital ...

The core of the lipoprotein, containing cholesterol ester and TG, is nonpolar and hydrophobic, and the outer layer of the lipoprotein particle (containing free cholesterol, phospholipid ...

A new study published in the Journal of American Medical Association showed that the innovative small interfering RNA (siRNA) medication olpasiran (Amgen) can effectively reduce lipoprotein(a) ...

The RNA inhibitor reduces levels of oxidized phospholipids, which are presumed to promote atherosclerosis, by more than 93%.

Fasting serum concentrations of total cholesterol, triglycerides, HDL-cholesterol (HDL-C), HDL2-cholesterol (HDL2-C), HDL3-cholesterol (HDL3-C), apolipoprotein A1 (Apo-A1), apolipoprotein B (Apo-B), ...